Vivex Biologics Publishes Promising Study on Long-term Outcomes of VIA Form+ in Spinal Fusion Vivex Biologics, Inc. has unveiled a significant peer-reviewed study showcasing the effectiveness of VIA Form+ in lumbar spinal fusion surgeries, noting impressive outcomes over three years.

Vivex Biologics Publishes Promising Study on Long-term Outcomes of VIA Form+ in Spinal Fusion #United_States #Miami #spinal_fusion #Vivex_Biologics #VIA_Form+